![Pioglitazone-hydrochloride-U-72107A-DataSheet-MedChemExpress_第1页](http://file4.renrendoc.com/view/4dce81ea5ecdf7a55469651cb2b394ca/4dce81ea5ecdf7a55469651cb2b394ca1.gif)
![Pioglitazone-hydrochloride-U-72107A-DataSheet-MedChemExpress_第2页](http://file4.renrendoc.com/view/4dce81ea5ecdf7a55469651cb2b394ca/4dce81ea5ecdf7a55469651cb2b394ca2.gif)
![Pioglitazone-hydrochloride-U-72107A-DataSheet-MedChemExpress_第3页](http://file4.renrendoc.com/view/4dce81ea5ecdf7a55469651cb2b394ca/4dce81ea5ecdf7a55469651cb2b394ca3.gif)
![Pioglitazone-hydrochloride-U-72107A-DataSheet-MedChemExpress_第4页](http://file4.renrendoc.com/view/4dce81ea5ecdf7a55469651cb2b394ca/4dce81ea5ecdf7a55469651cb2b394ca4.gif)
下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPioglitazone hydrochlorideCat. No.: HY-14601CAS No.: 112529-15-4Synonyms: U 72107A; AD 4833分式: CHClNOS分量: 392.9作靶点: PPAR作通路: Cell Cycle/DNA Damage储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DM
2、SO : 100 mg/mL (254.52 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.5452 mL 12.7259 mL 25.4518 mL5 mM 0.5090 mL 2.5452 mL 5.0904 mL10 mM 0.2545 mL 1.2726 mL 2.5452 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体
3、内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.36 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (6.36 mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% corn oil1
4、/3 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/mL (6.36 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Pioglitazone种有效,选择性的 PPAR 激动剂,亲和结合到 PPAR 配体结合域。作于和PPAR,EC50 分别为 0.93 和 0.99 M。IC50 & Target PPAR PPAR PPAR0.01 M (EC50, Human PPAR) 0.93 M (EC50, Human PPAR 43 M (EC50, Human PPAR)体外
5、研究 AGEs-induced beta cell necrosis is completely abrogated by adding Pioglitazone to the AGEs culturemedium. Furthermore Pioglitazone completely prevented any AGEs-induced increment in caspase-3activation, thereby restoring caspase-3 activity to the same levels as the control cells. As expected AG i
6、sable to counteract AGEs-induced impaired viability 2.体内研究 The serum-free fatty acid and triglyceride levels as well as adipocyte sizes in ob/ob and adipo-/- ob/ob miceare unchanged after 10 mg/kg Pioglitazone but are significantly reduced to a similar degree after 30 mg/kgPioglitazone. Moreover, th
7、e expressions of TNF and resistin in adipose tissues of ob/ob and adipo-/- ob/obmice are unchanged after 10 mg/kg Pioglitazone but are decreased after 30 mg/kg Pioglitazone. Thus,Pioglitazone-induced amelioration of insulin resistance and diabetes may occur adiponectin dependently inthe liver and ad
8、iponectin independently in skeletal muscle 3. Pioglitazone (10 mg/kg per d) treatmentsignificantly attenuates the loss of body weight (BW) and cardiac hypertrophy. Pioglitazone treatmentsignificantly reduces the elevated serum glucose levels and markedly improved the associated dyslipidemia.Furtherm
9、ore, there is a slight but significant increase in serum creatinine level in D rats over their N controls(P 4.PROTOCOLCell Assay 2 In order to evaluate cell proliferation, HIT-T15 cells are seeded on 96-well plates (3104 cells/well) andcultured for 5 days as described. Viable cells are determined us
10、ing the Cell Titer 96 Aqueous One SolutionCell Proliferation Assay. To evaluate cell apoptosis and cell necrosis, HIT-T15 cells are plated on 6-welldishes (7105 cells/well) for 5 days in standard conditions (CTR) or in the presence of AGEs (AGEs) with orwithout Pioglitazone (0.5 or 1 M) or AG (1 mM)
11、. They are then processed to measure both the activity ofcaspase-3 and the activity of lactate dehydrogenase (LDH) (a stable cytosolic enzyme that is a marker of cellmembrane damage and cell death due to necrosis) using Cytotox 96 Non Radioactive Cytotoxicity Assay 2.MCE has not independently confir
12、med the accuracy of these methods. They are for reference only.Animal Mice 3Administration 34 10 mg/kg Pioglitazone HCl or vehicle (0.25% carboxymethylcellulose) is adnimistered to ob/ob and adipo-/-ob/ob mice by oral gavage once daily for 14 consecutive days. 30 mg/kg Pioglitazone or vehicle is als
13、oadnimistered to ob/ob and adipo-/- ob/ob mice by oral gavage once daily for 14 consecutive days.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemERats 4Male Wistar albino rats (weighing 25020 g) are ued.Rats that achieved serum glucose level 250 mg/dLand serum creatinine level 1.5 mg/dL are divided
14、into 2 groups (n=10 per each group): diabeticnephropathic (DN) group in which rats received an equal amount of vehicle (0.5% carboxy methyl cellulose)and Pioglitazone-treated (DN+Pio) group in which rats treated with Pioglitazone. Pioglitazone (10 mg/kg BW)is given orally by gastric gavage, once dai
15、ly, for 4 weeks.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 Nutr Metab. 2019 Mar. Int J Oncol. 2018 Aug;53(2):551-566. Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F137-F151. J Diabetes Res. 2019 Feb 3;2019:5245063. Mol Med Rep. 2019 Ja
16、n;19(1):400-406.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Kuwabara K, et al. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-4-5-methyl-2-(4-methylphenyl)-4-oxazolylbutyl-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases
17、 plasma triglyceride and glucose leve2. Puddu A, et al. Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. Regul Pept. 2012 Aug 20;177(1-3):79-84.3. Kubota N, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. JBiol Chem. 2006 Mar 31;281(13):8748-55.4. Elrashidy RA, et al. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabet
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025届高三语文一轮复习:《五代史伶官传序》文言知识梳理
- 工程质量验收标准
- 九年级语文探究答案
- 商务礼仪试题(卷)全套与答案解析
- 保护环境主题班会教案课件设计
- 保护眼睛科学用眼课件
- 茂名市信宜市镇隆镇社区工作者招聘考试试题及答案2024
- 菏泽市巨野县章缝镇社区工作者招聘考试试题及答案2024
- 绍兴市嵊州市浦口街道社区工作者招聘考试试题及答案2024
- 聊城市东阿县鱼山镇社区工作者招聘考试试题及答案2024
- 半自动闭塞办理方法讲解
- 法律案例分析100例范文
- 2025年高考数学一轮复习(基础版)课时精讲第4章 §4.4 简单的三角恒等变换(含解析)
- 第1.1课 《中国人民站起来了》教案-【中职专用】高一语文教案(高教版2023基础模块下册)
- 第四单元 资本主义制度的确立(背诵清单)高一《历史》同步课堂(中外历史纲要下)
- 生育力保存共识解读(女性)
- 2024年粤沪版九年级物理上册知识点
- 情商认知与提升智慧树知到期末考试答案章节答案2024年河南大学
- DZ∕T 0302-2017 煤炭地质勘查图例图式(正式版)
- 2024河南郑州惠济区纪委监委事业单位招聘25人历年公开引进高层次人才和急需紧缺人才笔试参考题库(共500题)答案详解版
- 医生进修汇报总结
评论
0/150
提交评论